Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pioglitazone plus glimepiride versus glimepiride monotherapy in type 2 diabetes
2006-002271-41Phase 3Completed
- Sponsor
- Takeda
- Start
- Aug 2006
- Modality
- Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of pioglitazone and glimepiride in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Takeda. Primary endpoint: Change in HOMA-B score. Started Aug 2006; status: completed.
02
Drugs
pioglitazoneglimepiride
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2006-002271-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-002271-41.